Does removing mannitol and voluven from the priming fluid of the cardiopulmonary bypass circuit have clinical effects?

Journal of Extra-Corporeal Technology

Volumn 46, Issue 1, 2014, Pages 77-83

  Haydock, Matthew D ^a   Kruger, Cornelis ^a   Willcox, Timothy ^a,b   Haydock, David A ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cardiopulmonary bypass; Physiology

Indexed keywords

CREATININE; FRESH FROZEN PLASMA; HEMOGLOBIN; HETASTARCH; MANNITOL; POTASSIUM; SODIUM;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BODY WEIGHT; CARDIOPULMONARY BYPASS; CARDIOPULMONARY BYPASS EQUIPMENT; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; FEMALE; FLUID BALANCE; HEART ATRIUM FIBRILLATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; OUTCOME ASSESSMENT; PERFUSION PRESSURE; POSTOPERATIVE COMPLICATION; POTASSIUM BLOOD LEVEL; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; VERY ELDERLY;

AGED; BLOOD COMPONENT REMOVAL; BLOOD SUBSTITUTES; CARDIOPULMONARY BYPASS; FEMALE; HEMOFILTRATION; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; MALE; MANNITOL; MIDDLE AGED; NEW ZEALAND; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84897872381     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg. 2011;91:944-82.
2. Menkis AH, Martin J, Cheng DCH, et al. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: A consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2012;7:229-41.
3. Rosengart TK, DeBois W, O'Hara M, et al. Retrograde autologous priming for cardiopulmonary bypass: A safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998;115:426-39.
4. Shann KG, Likosky DS, Murkin JM, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283-90.
5. Himpe D. Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: A meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg. 2003;54:207-15.
6. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012;144:223-30.
7. Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: Meta-analysis of controlled trials. J Cardiothorac Vasc Anesth. 2004;18:429-37.
8. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: A meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001;72:527-33; discussion 534.
9. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012; 367:1901-11.
10. Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734-45.
11. Pierson DJ. Complications associated with mechanical ventilation. Crit Care Clin. 1990;6:711-24.
12. Carson J, Spence R, Poses R, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet. 1988;331:727-9.
13. Dial S, Delabays E, Albert M, et al. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. J Thorac Cardiovasc Surg. 2005;130:654-61.
14. Roth-Isigkeit A. Borstel TV, Seyfarth M, Schmucker P. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-), IL-1, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery, with cardiopulmonary bypass without and with correction for haemodilution. Clin Exp Immunol. 1999;118:242-6.
15. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients [Update of Cochrane Database Syst Rev. 2012;6:CD000567; PMID: 22696320]. Cochrane Database Syst Rev. 2013;2:CD000567.
16. Chelemer SB, Prato BS, Cox PM Jr, O'Connor GT, Morton JR. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg. 2002;73:138-42.
17. Engoren MC, Habib RH, Zacharias A, et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002;74:1180-6.
18. Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest. 1999;116:1233-9.
19. Habib RH, Zacharias A, Schwann TA, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med. 2005;33:1749-56.
20. Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest. 2001;119:1461-8.
21. Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S. Determinants of hospital mortality after coronary artery bypass grafting. Chest. 1999;115:1598-603.
22. Vamvakas EC, Carven JH. RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronary artery bypass graft surgery: The effects of confounding factors. Transfus (Paris). 2000;40:832-9.
23. Ali MA, Saleh M. Selection of optimal quantity of hydroxyethyl starch in the cardiopulmonary bypass prime. Perfusion. 2004;19:41-5.
24. Fisher AR, Jones P, Barlow P, et al. The influence of mannitol on renal function during and after open-heart surgery. Perfusion. 1998;13:181-6.